New breast cancer guidelines call for first mammogram at age 40 but stop short of annual screening
08 May 2024
The Preventive Services Task Force (USPSTF) officially updated its recommendations this week for who should be screened for breast cancer and when, advising that women should have their first mammogram earlier in life but not going as far as to urge annual exams.
WHO proposes recommendations for preventing nitrosamine contamination
07 May 2024
The World Health Organization (WHO)’s draft guidance on nitrosamines is applicable to manufacturers of excipients, active pharmaceutical ingredients (APIs) and finished pharmaceutical products.
Batyr Berdyklychev is now head of the WHO office in Russia
07 May 2024
Batyr Berdyklychev has become the new head of the WHO office in the Russian Federation. He replaced Melita Vujnovic, who had served in this position since March 2017. After she left office in January 2024, Bakhtygul Karryeva served as the organization’s acting representative in Russia.
Russia expects more medical tourism due to the world’s first drug for ankylosing spondylitis
07 May 2024
Russian Health Minister Mikhail Murashko commented on the registration of the world’s first drug capable of defeating ankylosing spondylitis, developed by the Russian compamy Biocad together with scientists from the Pirogov Russian National Research Medical University and the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry. He emphasized that participants in clinical trials noted the high effectiveness of the drug.
Health Ministry registered Russian drug for ankylosing spondylitis
06 May 2024
The Ministry of Health of the Russian Federation has registered a domestic drug for the treatment of ankylosing spondylitis, which is the first drug in the world that can potentially not only relieve the symptoms of the disease, but also stop its progression.
How gut enzymes could make universal donor blood possible
06 May 2024
In an article published April 26 in Nature Microbiology, a team of researchers from the Technical University of Denmark (DTU) and Lund University detailed how they discovered gut bacteria enzymes that remove not only A and B antigens from red blood cells but also other components that have historically hampered progress toward universal donor blood.
Research calls for greater investment in Alzheimer’s clinical trials
03 May 2024
Despite some challenges, for the Alzheimer’s drug development pipeline, 2024 is a “learning year”, an expert on the disease says.
Stress impact on protein particle formation for monoclonal antibody formulation
03 May 2024
The driving factor for protein particle formation is surface mediated in protein only formulations in manufacturing, research asserts.
Health Ministry registered Russian drug for ankylosing spondylitis
02 May 2024
The Federal Service for Veterinary and Phytosanitary Supervision (Rosselkhoznadzor) has reported that Russian manufacturers are actively replacing imported veterinary drugs. Overall, there is an ample supply of domestic drugs available for treating and preventing parasitic infections in domestic animals in the Russian Federation.
Production of finished drugs in Russia grew by 13.8%
02 May 2024
Production volume of drugs in Russia increased by 13.8% in the first quarter of 2024 compared to 2023. 993 million packages were released onto the market, which is 1.4% more than in the same period in 2023. The analytical company RNC Pharma recently published a report containing this data.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
New breast cancer guidelines call for first mammogram at age 40 but stop short of annual screening
08 May 2024
WHO proposes recommendations for preventing nitrosamine contamination
07 May 2024
Batyr Berdyklychev is now head of the WHO office in Russia
07 May 2024
Russia expects more medical tourism due to the world’s first drug for ankylosing spondylitis
07 May 2024